CD38 and B-cell chronic lymphocytic leukemia: We carried out this study to estimate the level of CD38 expression in CLL patients, to find its association with baseline clinical and laboratory parameters at presentation, and to determine a cutoff level for a CD38 appearance that is more likely to be associated with the clinical and laboratory findings of CLL patients.